Pharmaceutical

Image

Middle East and Africa Psychedelic Drugs Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Published Report
  • Jun 2022
  • MEA
  • 350 Pages
  • No of Tables: 84
  • No of Figures: 52

Middle East and Africa Psychedelic Drugs Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 12.14 Million
Diagram Market Size (Forecast Year) USD 27.94 Million
Diagram CAGR %

Middle East and Africa Psychedelic Drugs Market, By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) Industry Trends and Forecast to 2029

Middle East and Africa Psychedelic Drugs Market Analysis and Insights

Psychedelic drugs involve various types of chemical substances including lysergic acid diethylamide (LSD) and chemical extracted from plants. These drugs have the ability to change or enhance the sensory perceptions, thought processes, energy levels and have also been reported to facilitate spiritual experiences.

Psychedelic Drugs Market

Psychedelic Drugs Market

The psychedelic drugs can be categorized into empathogens and dissociative drugs (such as phenylcyclohexyl piperidine (PCP)) and serotonergic (classic hallucinogens) such as LSD. Both types of psychedelic drugs can cause hallucinations and feeling of sensation, moreover, dissociative drugs can make a person to fell out of control from their body or environment and makes them feel disconnected. Based on the source, psychedelic drugs have been categorized under natural and synthetic types.

These drugs have wide applications in the treatment of major depressive disorder, post-traumatic stress disorder, panic disorder, treatment-resistant depression and opiate addiction among others. Psychedelic drugs are also known by several other names such as lysergic acid derivative (LSD) which are also known as blotter, dots, sugar, acid, trips and window pane, ketamine are also known as vitamin K, bump, green, K/special K, purple and super acid, PCP are also known as angel/angel dust, boat/love boat, peace, killer weed, super grass and ozone.

Middle East and Africa market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 11.1% in the forecast period of 2022 to 2029 and is expected to reach USD 27.94 million by 2029 from USD 12.14 million in 2021.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019-2014)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)

Countries Covered

South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa

Market Players Covered

The major companies which are dealing in the market are Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.), Hikma Pharmaceuticals PLC, Pfizer Inc., F. Hoffmann-La Roche Ltd, among others

Market Definition

Psychedelic drugs involve various types of chemical substances including lysergic acid diethylamide (LSD) and chemical extracted from plants. These drugs have the ability to change or enhance the sensory perceptions, thought processes, energy levels and have also been reported to facilitate spiritual experiences.

The psychedelic drugs can be categorized into empathogens and dissociative drugs (such as phenylcyclohexyl piperidine (PCP)) and serotonergic (classic hallucinogens) such as LSD. Both types of psychedelic drugs can cause hallucinations and feeling of sensation, moreover, dissociative drugs can make a person to fell out of control from their body or environment and makes them feel disconnected. Based on the source, psychedelic drugs have been categorized under natural and synthetic types.

These drugs have wide applications in the treatment of major depressive disorder, post-traumatic stress disorder, panic disorder, treatment-resistant depression and opiate addiction among others. Psychedelic drugs are also known by several other names such as lysergic acid derivative (LSD) which are also known as blotter, dots, sugar, acid, trips and window pane, ketamine are also known as vitamin K, bump, green, K/special K, purple and super acid, PCP are also known as angel/angel dust, boat/love boat, peace, killer weed, super grass and ozone.

Psychedelic Drugs Market Dynamics

Drivers

  • Growing Acceptance Of Psychedelic Drugs For Treating Depression

Psychedelics have achieved a large popularity within the last decade as are familiarly involved with human mental healing and treatment practices and have the power of mind- healing. The growing researchers and scientist are exploring psychedelic drugs therapeutic value and compounds which could be a new treatment option for people with depression. Continuous research and development in the psychedelic drugs has increased the acceptance of psychedelics medication. Psychedelic drugs promising outcomes have increased the usage of psychedelic drugs across the South Africa and other regions which leads to increasing demand for psychedelic drugs, hence these factors are expected to act as drivers for the growth of the market.

  • Increasing Prevalence Of Depression And Mental Disorders

Mental disorders (or mental illnesses) affects persons feeling, mood, thinking, and behaviour and can be long-lasting (chronic) or occasional. Depression and mental disorders have the ability to affect individual’s capacity by virtue of which they perform their everyday tasks. There are numerous dissimilar types of mental disorders. Depression and mental disorders have increased globally due to various factors including family history and genes, abuse or stress, biological factors, usage of alcohol or recreational drugs and many others.

Additionally, increasing consumption of illicit substances has increased depression and mental disorders. Thus, increasing prevalence of depression and mental disorders are increasing the demand for psychedelic drugs which is expected to act as driver for the growth of the market.

  • Rising Awareness Towards Mental Health

As mental illness has adversely impacted the people ability to carry out normal functions of their life, this has become important to create awareness among people regarding the different types of cause, disorders it leads to and the treatment options available in the market in order to cure such life-devastating illness. In order to raise awareness several organizations and companies are launching campaigns and adoption initiatives. This in turn allows patients to opt for effective treatment option as per the disease cause and reported symptoms. Advertisements, awareness campaigns, and others have increased the awareness for psychedelic drugs. The awareness campaigns have encouraged people to select appropriate treatment for mental disorders procedures and professionals which is increasing the demand of psychedelic drugs. For this reason, rising awareness towards mental health is expected to act as driver for the market growth.

Opportunity

  • Increasing R&D Activities In Psychedelic Drugs

Psychedelic plants and fungi have been used in indigenous medicinal traditions for millennia. New psychedelic drugs development research has initiated by Albert Hofmann in 1938. He has synthesized the first lysergic acid diethylamide (LSD-25) and now recognized as the first person to ingest LSD after five years later. Hofmann was unaware of the significant effects and actions posed by that product. After a growing period of cultural and scientific exploration in the 1950s and 60s, psychedelic drug development research was slackened to a near halt. Increasing research and development expenditure in the psychedelic drugs is creating new opportunities in the market. Thus, increasing R&D activities in psychedelic drugs are acting as an opportunity for the growth of the market.

Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the psychedelic drugs market in the forecast period of 2022-2029.

Restraint/Challenge

  • High Cost Of Psychedelic Drugs

However, the high cost associated with psychedelic drugs will impede the growth rate of psychedelic drugs market. Additionally, stringent rules and regulations will further challenge the market in the forecast period mentioned above.

This psychedelic drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more information on psychedelic drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post COVID-19 Impact on psychedelic drugs market

The COVID-19 has positively affected the market. Lockdowns and isolation during pandemics complicate the disease management and medication adherence. Hence the use of various treatment drugs have widely increased in the world’s population. Hence, the pandemic has effected positively on this market.

Recent Development

  • In August 2020, Janssen Pharmaceuticals, Inc. received approval for its Spravato nasal spray indicated for treatment of suicidal people. As approximately 11% to 12% of Americans suffers from major depressive disorder that led them to commit suicide, this approval provided these patients with a remarkable therapy and paved the way for the company to generate more revenue.

Middle East and Africa Market Scope

Middle East and Africa psychedelic drugs market is segmented into source, type, drugs, application, route of administration, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Source

  • Synthetic
  • Natural

On the basis of source, the Middle East and Africa psychedelic drugs market is segmented into synthetic and natural.

Type

  • Empathogens
  • Dissociatives
  • Others

On the basis of type, the Middle East and Africa psychedelic drugs market is segmented into empathogens, dissociatives, and others.

Drugs

  • Gamma-Hydroxybutyric Acid
  • Ketamine
  • Psilocybin
  • Others

On the basis of drugs, the Middle East and Africa psychedelic drugs market is segmented into gamma-hydroxybutyric acid, ketamine, psilocybin and others.

.Application

  • Narcolepsy,
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Opiate Addiction
  • Post-Traumatic Stress Disorder
  • Others

On the basis of application, the Middle East and Africa psychedelic drugs market is segmented into narcolepsy, treatment resistant depression, major depressive disorder, opiate addiction, post-traumatic stress disorder and others.

Route of Administration

  • Oral
  • Inhalation
  • Injectable

On the basis of route of administration, the Middle East and Africa psychedelic drugs market is segmented into oral, inhalation, injectable.

End User

  • Hospital
  • Specialty Clinics
  • Homecare
  • Others

On the basis of end user, the Middle East and Africa psychedelic drugs market is segmented into hospital, specialty clinics, homecare, and others.

Distribution Channel

  • Hospitals Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Psychedelic Drugs Market

On the basis of distribution channel, the Middle East and Africa psychedelic drugs market is segmented into hospitals pharmacy, retail pharmacy and online pharmacy.

Psychedelic drugs Market Regional Analysis/Insights            

The psychedelic drugs market is analysed and market size insights and trends are provided by country, source, type, drugs, application, route of administration, end user and distribution channel as referenced above.

The countries covered in this report are South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa.

Saudi Arabia country in the Middle East and Africa dominates the psychedelic drugs market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to ongoing clinical trials in the region and rapid research development is boosting the market.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Psychedelic Drugs Market Share Analysis

The psychedelic drugs market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on psychedelic drugs market.

Some of the major players operating in the psychedelic drugs market are Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.), Hikma Pharmaceuticals PLC, Pfizer Inc., F. Hoffmann-La Roche Ltd, among others.

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Middle East and Africa vs. Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report


SKU-

TABLE 1 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, PIPELINE ANALYSIS

TABLE 2 PSYCHEDELICS RESEARCH STUDIES, IN EUROPE

TABLE 3 MENTAL ILLNESS IN THE U.S. ADULTS, IN 2020

TABLE 4 MENTAL DISORDERS, IN THE U.S. ADULTS, IN 2020

TABLE 5 DRUG DEVELOPMENT PATHWAY FOR FDA APPROVAL OF NEW MEDICATIONS

TABLE 6 THE 1971 UN CONVENTION ON PSYCHOTROPIC SUBSTANCES

TABLE 7 MAGIC MUSHROOMS PRICES FOR RESEARCHERS, IN THE U.S.

TABLE 8 COST OF PSYCHEDELIC DRUGS

TABLE 9 PSYCHEDELIC DRUGS R&D ACTIVITIES

TABLE 10 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA EMPATHOGENS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA DISSOCIATIVES IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA SYNTHETIC IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA NATURAL IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA GAMMA-HYDROXYBUTYRIC ACID IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA KETAMINE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA PSILOCYBIN IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA NARCOLEPSY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA TREATMENT RESISTANT DEPRESSION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA MAJOR DEPRESSIVE DISORDER IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA OPIATE ADDICTION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA POST-TRAUMATIC STRESS DISORDER IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA ORAL IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA INHALATION IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA INJECTABLE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA HOSPITALS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA SPECIALTY CLINICS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA HOMECARE IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA OTHERS IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA HOSPITALS PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA RETAIL PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA ONLINE PHARMACY IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 47 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 50 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 51 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 52 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 53 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 54 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 55 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 56 SAUDI ARABIA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 57 ISRAEL PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 58 ISRAEL PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 59 ISRAEL PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 60 ISRAEL PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 61 ISRAEL PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 62 ISRAEL PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 63 ISRAEL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 64 EGYPT PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 65 EGYPT PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 66 EGYPT PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 67 EGYPT PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 68 EGYPT PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 69 EGYPT PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 70 EGYPT PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 71 UAE PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 72 UAE PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 73 UAE PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 74 UAE PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 75 UAE PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 76 UAE PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 77 UAE PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 78 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 79 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY SOURCE, 2020-2029 (USD MILLION)

TABLE 80 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY DRUGS, 2020-2029 (USD MILLION)

TABLE 81 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 82 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 83 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 84 SOUTH AFRICA PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The major countries operating in the Middle East and Africa Psychedelic Drugs Market are Saudi Arabia, Israel, Egypt, U.A.E, South Africa and Rest of Middle East and Africa.
Rising prevalence of mental depression and anxiety and availability of off label drugs are the significant factors flourishing the growth of the Middle East and Africa Psychedelic Drugs Market
The Middle East and Africa Psychedelic Drugs Market is to grow at a CAGR of 11.1% during the forecast by 2029.
The market value for Middle East and Africa Psychedelic Drugs Market is expected USD 27.94 million by 2029.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials